Adma Biologics Inc. (ADMA)
NASDAQ · Healthcare
Adma Biologics Inc. Gross Profit 2020–2025
Adma Biologics Inc. annual/quarterly gross profit history and growth rate from 2020 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Adma Biologics Inc. gross profit for the quarter ending March 31, 2026 was 80.8 M, a 32.17% increase year-over-year.
- Adma Biologics Inc. gross profit for the twelve months ending March 31, 2026 was 312.4 M.
- Adma Biologics Inc. annual gross profit for 2025 was 292.8 M, a 33.35% increase from 2024.
- Adma Biologics Inc. annual gross profit for 2024 was 219.6 M, a 146.85% increase from 2023.
- Adma Biologics Inc. annual gross profit for 2023 was 88.9 M, a 152.21% increase from 2022.
- Adma Biologics Inc. annual gross profit for 2022 was 35.3 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Adma Biologics Inc. Gross Profit — FAQ
Adma Biologics Inc. (ADMA) gross profit over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Adma Biologics Inc.'s gross profit?
Adma Biologics Inc. (ADMA) reported gross profit of $293M for fiscal 2025.
Where can I see ADMA's gross profit history?
The chart and table above show Adma Biologics Inc.'s gross profit by year and by quarter, including the growth rate.